Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Exponent, Inc.    EXPO

EXPONENT, INC. (EXPO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Exponent : Society of Environmental Toxicology and Chemistry (SETAC) Annual Meeting

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2017 | 01:09am CEST
Exponent scientists will be presenting and chairing sessions at the 38th Annual Meeting of the Society of Environmental Toxicology and Chemistry (SETAC) November 12 through November 16, 2017 in Minneapolis, Minnesota.

The theme of the 2017 meeting is, 'Toward a Superior Future: Advancing Science for a Sustainable Environment.' The conference will allow attendees to share and exchange information and ideas to help develop and find solutions to the world's most challenging environmental problems. Over 2,400 scientists from over 40 countries will be in attendance.

SETAC is a non-profit, worldwide professional society whose mission is to support the development of principles and practices for protection, enhancement and management of sustainable environmental quality and ecosystem integrity.

For more information, please see the event website and visit us at Booth #507.

Exponent Platform and Poster Presentations (download our Presentation Handout).
Session Chairs

  • Susan Kane Driscoll: Microplastics in the Aquatic Environment: Fate and Effects
  • Jane Staveley: Pharmaceuticals in the Environment - Potential Environmental and Human Health Impacts

Monday, November 13 - Platform
  • Advancements in Technologies Often Change Previous Norms for Recycling Strategies
    - William Goodfellow, Yoko Masue-Slowey
  • Application of Food Web Models at Superfund Sites: Legal and Political Implications
    - Kirk O'Reilly
  • Addressing White Hat Bias: Lessons from Environmental Litigation
    - Katherine Palmquist
  • Scientific Integrity Issues in Environmental Toxicology
    - Anne Fairbrother and William Goodfellow

Tuesday, November 14 - Platform
  • Toxicity Assessments for NPDES Compliance: Traditional TSD Methods versus the TST Approach
    - William Goodfellow, Susan Paulsen, Katie Marjanovic

Tuesday, November 14 - Posters
  • How Statistical Artifacts Affect the Reliability of Toxicity Thresholds Calculated from Distribution Tails of Field Monitoring Data
    - Roxolana Kashuba, William Goodfellow
  • A Metabolomics Evaluation of Oxygen Containing Compounds Identified In Groundwater from Petroleum Fuel Release Sites
    - Kirk O'Reilly, Sungwoo Ahn

Wednesday, November 15 - Platform
  • PAH Source Identification in Urban Settings: Avoiding the Sin of Oversimplification of Pyrogenic Sources
    - Jaana Pietari, Tarek Saba, and Paul Boehm
  • Application of Receptor Models to Characterize Sources of PAHs in Urban Sediment: Use of Site Specific versus Generic Source Profiles
    - Kirk O'Reilly
Wednesday, November 15 - Posters
  • Use of Read-Across for Testing Estrogen, Androgen, Thyroid, and Steroidogenesis Pathways in Vertebrate Ecological Receptors
    - Margaret McArdle, Jane Staveley, and Elaine Freeman
  • Laboratory, Field, and Analytical Procedures for Using Passive Sampling in the Evaluation of Contaminated Sediments: User's Manual Overview
    - Susan Kane Driscoll
  • Tracking PAH Sources to the Gowanus Canal Superfund Site
    - Tarek Saba, Linda Cook, Natalie Johnson, Jaana Pietari, and Paul Boehm

Thursday, November 16 - Platform
  • Assessing Ecological Risk from the use of a Veterinary Medicinal Product in Cattle: Innovative Approaches for Wildlife Exposure Assessment
    - Josie Nusz and Jane Staveley
  • Environmental Assessment of a Veterinary Drug (Revalor-XR) Containing Trenbolone Acetate and 17β-Estradiol
    - Jane Staveley, Qingli Ma, and Jane Ma

Thursday, November 16 - Posters
  • Groundwater and Surface Water Exposure Assessments of a Veterinary Drug (Revalor-XR) Containing Trenbolone Acetate and 17β-Estradiol
    - Qingli Ma, Jane Staveley, Jane Ma

Exponent Inc. published this content on 12 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 November 2017 00:08:07 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPONENT, INC.
07/11EXPONENT : 14th Annual Product Safety and Liability Conference
PU
07/10THE CHANGING NATURE OF DRIVING : Implications of Advanced Driver Assistance Syst..
PU
07/03EXPONENT : Dr. Ezra Jampole wins Younger Member Award from the Earthquake Engine..
PU
07/03EXPONENT : Leading Scientists in Developmental and Reproductive Toxicology and E..
PU
07/02EXPONENT : to Announce Second Quarter of Fiscal Year 2018 Results and Host Quart..
AQ
06/23EXPONENT : International Conference & Expo
PU
06/11EXPONENT : ISC National Capital Region June Chapter Meeting
PU
06/09EXPONENT : International Society of Offshore and Polar Engineers (ISOPE) 2018 As..
PU
06/08EXPONENT, INC. : SPLIT: 2 of 1
FA
06/07EXPONENT, INC. : Ex-dividend day for
FA
More news
News from SeekingAlpha
07/18Notable earnings after Thursday?s close 
06/08Exponent (EXPO) Presents At Baird Global Consumer, Technology And Services Co.. 
05/15EXPONENT : The Historical Returns Have Been Phenomenal And There Is A Long Way A.. 
04/20Exponent flat on Q1 results. 
04/19Exponent's (EXPO) CEO Paul Johnston on Q1 2018 Results - Earnings Call Transc.. 
Financials ($)
Sales 2018 379 M
EBIT 2018 74,8 M
Net income 2018 67,9 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 39,28
P/E ratio 2019 35,71
Capi. / Sales 2018 6,88x
Capi. / Sales 2019 6,43x
Capitalization 2 606 M
Chart EXPONENT, INC.
Duration : Period :
Exponent, Inc. Technical Analysis Chart | EXPO | US30214U1025 | 4-Traders
Technical analysis trends EXPONENT, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 49,2 $
Spread / Average Target -2,4%
EPS Revisions
Managers
NameTitle
Catherine Ford Corrigan President & Chief Executive Officer
Paul R. Johnston Executive Chairman
Richard L. Schlenker CFO, Secretary, Principal Accounting Officer & EVP
Subbaiah V. Malladi Chief Technical Officer & Principal Engineer
John B. Shoven Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EXPONENT, INC.41.63%2 606
WORLDPAY INC7.04%27 176
CINTAS CORPORATION23.55%20 732
UNITED RENTALS-9.89%12 724
INTERTEK GROUP13.14%12 399
BUREAU VERITAS1.67%11 959